Afya Limited (NASDAQ:AFYA) Shares Sold by GSA Capital Partners LLP

GSA Capital Partners LLP trimmed its holdings in shares of Afya Limited (NASDAQ:AFYA) by 44.9% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 30,066 shares of the company’s stock after selling 24,546 shares during the quarter. GSA Capital Partners LLP’s holdings in Afya were worth $513,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in AFYA. Marshall Wace LLP raised its stake in shares of Afya by 41.8% during the 2nd quarter. Marshall Wace LLP now owns 336,985 shares of the company’s stock worth $5,948,000 after buying an additional 99,416 shares during the period. Millennium Management LLC raised its stake in shares of Afya by 45.0% during the 2nd quarter. Millennium Management LLC now owns 291,164 shares of the company’s stock worth $5,139,000 after buying an additional 90,383 shares during the period. Renaissance Technologies LLC raised its stake in shares of Afya by 19.7% during the 2nd quarter. Renaissance Technologies LLC now owns 266,500 shares of the company’s stock worth $4,704,000 after buying an additional 43,800 shares during the period. DekaBank Deutsche Girozentrale acquired a new position in shares of Afya during the 3rd quarter worth approximately $417,000. Finally, Cubist Systematic Strategies LLC raised its stake in shares of Afya by 136.9% during the 2nd quarter. Cubist Systematic Strategies LLC now owns 35,254 shares of the company’s stock worth $622,000 after buying an additional 20,370 shares during the period. 88.02% of the stock is owned by institutional investors and hedge funds.

Afya Stock Down 1.0 %

Shares of AFYA opened at $16.27 on Wednesday. The company has a debt-to-equity ratio of 0.51, a quick ratio of 1.60 and a current ratio of 1.60. Afya Limited has a one year low of $15.52 and a one year high of $22.48. The stock has a market capitalization of $1.52 billion, a price-to-earnings ratio of 13.12, a PEG ratio of 0.33 and a beta of 0.91. The stock has a 50 day moving average price of $16.77 and a 200 day moving average price of $17.25.

Analysts Set New Price Targets

Separately, UBS Group began coverage on Afya in a research report on Friday, August 30th. They set a “neutral” rating and a $19.50 price target for the company.

Afya Profile

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.